Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Receivables - Net (2018 - 2025)

Historic Receivables - Net for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $380.3 million.

  • AdaptHealth's Receivables - Net fell 520.82% to $380.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $380.3 million, marking a year-over-year decrease of 520.82%. This contributed to the annual value of $408.0 million for FY2024, which is 491.35% up from last year.
  • Per AdaptHealth's latest filing, its Receivables - Net stood at $380.3 million for Q3 2025, which was down 520.82% from $393.6 million recorded in Q2 2025.
  • AdaptHealth's Receivables - Net's 5-year high stood at $437.1 million during Q2 2024, with a 5-year trough of $260.8 million in Q1 2021.
  • In the last 5 years, AdaptHealth's Receivables - Net had a median value of $369.9 million in 2022 and averaged $371.6 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 15337.08% in 2021, then plummeted by 994.88% in 2025.
  • Quarter analysis of 5 years shows AdaptHealth's Receivables - Net stood at $359.9 million in 2021, then dropped by 0.21% to $359.1 million in 2022, then increased by 8.29% to $388.9 million in 2023, then rose by 4.91% to $408.0 million in 2024, then decreased by 6.79% to $380.3 million in 2025.
  • Its last three reported values are $380.3 million in Q3 2025, $393.6 million for Q2 2025, and $418.5 million during Q1 2025.